Seres Therapeutics, Inc.
MCRB
$17.03
$0.331.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.64M | 45.38M | 58.85M | 30.79M | 66.82M |
| Total Receivables | 830.00K | 1.16M | 2.76M | 2.07M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.06M | 2.15M | 4.47M | 5.81M | 6.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 51.53M | 48.69M | 66.08M | 38.67M | 72.93M |
|
|
|||||
| Total Current Assets | 51.53M | 48.69M | 66.08M | 38.67M | 72.93M |
| Net Property, Plant & Equipment | 83.25M | 86.42M | 89.41M | 92.44M | 95.48M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.70M | 8.70M | 8.70M | 8.70M | 10.34M |
| Total Assets | 143.47M | 143.80M | 164.18M | 139.81M | 178.74M |
|
|
|||||
| Total Accounts Payable | 1.68M | 2.20M | 2.17M | 4.08M | 8.25M |
| Total Accrued Expenses | 6.38M | 5.81M | 6.22M | 10.72M | 17.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.92M | 9.48M | 9.05M | 8.67M | 8.35M |
| Total Finance Division Other Current Liabilities | 4.45M | 13.45M | 13.89M | 17.75M | 30.52M |
| Total Other Current Liabilities | 4.45M | 13.45M | 13.89M | 17.75M | 30.52M |
| Total Current Liabilities | 22.43M | 30.94M | 31.32M | 41.22M | 64.83M |
|
|
|||||
| Total Current Liabilities | 22.43M | 30.94M | 31.32M | 41.22M | 64.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 75.33M | 77.96M | 80.50M | 82.97M | 85.27M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.01M | 1.95M | 1.90M | 1.84M | 4.72M |
| Total Liabilities | 99.78M | 110.85M | 113.72M | 126.03M | 154.82M |
|
|
|||||
| Common Stock & APIC | 1.00B | 998.22M | 995.88M | 991.88M | 986.38M |
| Retained Earnings | -957.07M | -965.27M | -945.42M | -978.10M | -962.46M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 43.70M | 32.95M | 50.47M | 13.78M | 23.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 43.70M | 32.95M | 50.47M | 13.78M | 23.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 43.70M | 32.95M | 50.47M | 13.78M | 23.92M |
|
|
|||||